ICD-10 Coding for Metastatic Breast Carcinoma(C41.9U, C50.0, C50.212)
Comprehensive guide to ICD-10 coding for metastatic breast carcinoma, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Metastatic Breast Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.912 | Malignant neoplasm of unspecified site of left female breast | Use when the primary site is confirmed as the left breast but specific quadrant is not documented. |
|
| C79.51 | Secondary malignant neoplasm of bone | Use when metastasis to bone is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Breast Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Breast Carcinoma.
Failing to document laterality of breast cancer.
Impact
Clinical: May affect treatment decisions., Regulatory: Increases audit risk., Financial: Potential for reduced reimbursement.
Mitigation
Always document laterality in clinical notes.
Using unspecified codes when specific details are available.
Impact
Reimbursement: May lead to reduced reimbursement due to unspecified coding., Compliance: Increases risk of audit findings., Data Quality: Decreases accuracy of clinical data.
Mitigation
Query provider for specific site and laterality.
Unspecified coding
Impact
Using unspecified codes when specific details are available.
Mitigation
Ensure documentation includes specific site and laterality.